Pharmacological and Endoscopic Interventions for Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

被引:0
|
作者
Palomera-Tejeda, Emmanuel [1 ]
Shah, Mihir Prakash [1 ]
Attar, Bashar M. [2 ,3 ]
Shah, Hassam [2 ]
Sharma, Bharosa [1 ]
Oleas, Roberto [1 ]
Kotwal, Vikram [2 ,3 ]
Gandhi, Seema [2 ]
Mutneja, Hemant Raj [2 ,3 ]
机构
[1] John H Stroger Jr Hosp Cook Cty, Dept Internal Med, Chicago, IL 60612 USA
[2] John H Stroger Jr Hosp Cook Cty, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA
[3] Rush Univ, Div Gastroenterol & Hepatol, Med Ctr, Chicago, IL USA
关键词
Endoscopic retrograde cholangiopancreatography; Post-ERCP pancreatitis; Rectal NSAIDs; Pancreatic duct stenting; Chronic statin use; Chronic aspirin use; Retrospective cohort study; ERCP PANCREATITIS; RISK-FACTORS; PREVENTION; COMPLICATIONS; INDOMETHACIN; METAANALYSIS; STATINS;
D O I
10.14740/gr1620
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Post-endoscopic retrograde cholangiopancreatogra-phy pancreatitis (PEP) represents the most common serious com-plication after endoscopic retrograde cholangiopancreatography (ERCP). Rectal non-steroidal anti-inflammatory drugs (NSAIDs) and pancreatic duct stenting (PDS) are the prophylactic interven-tions with more evidence and efficacy; however, PEP still represents a significant source of morbidity, mortality, and economic burden. Chronic statin use has been proposed as a prophylactic method that could be cheap and relatively safe. However, the evidence is conflict-ing. We aimed to evaluate the impact of endoscopic and pharmaco-logical interventions including chronic statin and aspirin use, on the development of PEP.Methods: A retrospective cohort study evaluated consecutive patients undergoing ERCP at John H. Stroger, Jr. Hospital of Cook County in Chicago from January 2015 to March 2018. Univariate and multivari-ate analyses were performed using logistic regression.Results: A total of 681 ERCPs were included in the study. Twelve (1.76%) developed PEP. Univariate, multivariate, and subgroup anal-yses did not show any association between chronic statin or aspirin use and PEP. PDS and rectal indomethacin were protective in patients undergoing pancreatic duct injection. Pancreatic duct injection, fe-male sex, and younger age were associated with a higher risk. History of papillotomy was associated with lower risk only in the univariate analysis (all P values < 0.05).Conclusion: Chronic use of statins and aspirin appears to add no ad-ditional benefit to prevent ERCP pancreatitis. Rectal NSAIDs, and PDS after appropriate patient selection continue to be the main pro-phylactic measures. The lower incidence at our center compared with the reported data can be explained by the high rates of rectal indo-methacin and PDS, the use of noninvasive diagnostic modalities for patient selection, and the expertise of the endoscopists.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 50 条
  • [21] Effects of Medications on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Li, N.
    Tieng, A.
    Novak, S.
    Fernandes, A.
    Jalal, P. K.
    Akerman, M.
    Sideridis, K.
    Bank, S.
    PANCREATOLOGY, 2010, 10 (2-3) : 238 - 242
  • [22] Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Elmunzer, B. Joseph
    DIGESTIVE ENDOSCOPY, 2017, 29 (07) : 749 - 757
  • [23] How to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Boskoski, Ivo
    Costamagna, Guido
    GASTROENTEROLOGY, 2020, 158 (08) : 2037 - 2040
  • [24] Post-endoscopic retrograde cholangiopancreatography pancreatitis: Overview and pathophysiology
    Koutroumpakis, Efstratios I.
    Papachristou, Georgios I.
    TECHNIQUES IN GASTROINTESTINAL ENDOSCOPY, 2014, 16 (04) : 150 - 155
  • [25] Post-Endoscopic Retrograde Cholangiopancreatography 2-Hour Amylase Level Is a Useful Predictor of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Hayashi, Shiro
    Nishida, Tsutomu
    Amano, Takahiro
    Sakamoto, Aisa
    Otake, Yuriko
    Takagi, Wataru
    Saiki, Hirotsugu
    Kondo, Hisashi
    Urabe, Makiko
    Takahashi, Kei
    Matsubara, Tokuhiro
    Yamamoto, Masashi
    Nakajima, Sachiko
    Fukui, Koji
    Inada, Masami
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB411 - AB411
  • [26] Current approaches and questions yet to be resolved for the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Saito, Hirokazu
    Fujimoto, Atsushi
    Oomoto, Kana
    Kadowaki, Yoshitaka
    Tada, Shuji
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2022, 14 (11): : 657 - 666
  • [27] Is post-endoscopic retrograde cholangiopancreatography pancreatitis the same as acute clinical pancreatitis?
    Tetsuya Mine
    Journal of Gastroenterology, 2007, 42 : 265 - 266
  • [28] Implementation of post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: A tertiary-hospital experience
    Mahendran, A.
    Knox, C.
    Almeida, J.
    Kaffes, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 219 - 220
  • [29] Optimal endoscopic techniques to reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Shastri, Nikhil J.
    Piraka, Cyrus R.
    TECHNIQUES IN GASTROINTESTINAL ENDOSCOPY, 2014, 16 (04) : 162 - 168
  • [30] Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Mukai, Shuntaro
    Itoi, Takao
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (06) : 709 - 722